Submission ID

Page 1 of 7 - Cover trn:oid:::3012:558570917

Page

1683670-1393
1683670_c.docx
University

Document Details

Submission ID
trn:oid:::3012:558570917 5 Pages

4,720 Words
Submission Date
Apr 19, 2025, 9:12 AM GMT+3 53,078 Characters

Download Date
Apr 19, 2025, 9:13 AM GMT+3

File Name 1683670_c.docx

File Size
33.6 KB

Submission ID
Page 1 of 7 - Cover trn:oid:::3012:558570917
Page
 Submission ID
Page 2 of 7 - AI Writing trn:oid:::3012:558570917
Overview

0% detected as AI Caution: Review required.

The percentage indicates the combined amount of likely AI-generated It is essential to understand the limitations of AI detection before making
decisions about a student’s work. We encourage you to learn more about
text as well as likely AI-generated text that was also likely AI-
Turnitin’s AI detection capabilities before using the tool.
paraphrased.

Detection Groups
1 AI-generated only 0%
Likely AI-generated text from a large-language model.

2 AI-generated text that was AI-paraphrased 0%

Likely AI-generated text that was likely revised using an AI-
paraphrase tool or word spinner.

Disclaimer
Our AI writing assessment is designed to help educators identify text that might be prepared by a generative AI tool. Our AI writing assessment may not always be
accurate (it may misidentify writing that is likely AI generated as AI generated and AI paraphrased or likely AI generated and AI paraphrased writing as only AI
generated) so it should not be used as the sole basis for adverse actions against a student. It takes further scrutiny and human judgment in conjunction with an
organization's application of its specific academic policies to determine whether any academic misconduct has occurred.

Frequently Asked Questions

How should I interpret Turnitin's AI writing percentage and false positives?

The percentage shown in the AI writing report is the amount of qualifying text within the submission that
Turnitin’s AI writing detection model determines was either likely AI-generated text from a large-language model or
likely AI-generated text that was likely revised using an AI-paraphrase tool or word spinner.

False positives (incorrectly flagging human-written text as AI-generated) are a possibility in AI models.

AI detection scores under 20%, which we do not surface in new reports, have a higher likelihood of false positives. To
reduce the likelihood of misinterpretation, no score or highlights are attributed and are indicated with an
asterisk in the report (*%).

The AI writing percentage should not be the sole basis to determine whether misconduct has occurred. The
reviewer/instructor should use the percentage as a means to start a formative conversation with their student
and/or use it to examine the submitted assignment in accordance with their school's policies.

What does 'qualifying text' mean?

Our model only processes qualifying text in the form of long-form writing. Long-form writing means individual sentences contained in paragraphs
that make up a longer piece of written work, such as an essay, a dissertation, or an article, etc. Qualifying text that has been determined to
be likely AI-generated will be highlighted in cyan in the submission, and likely AI-generated and then likely AI-paraphrased will be
highlighted purple.

Non-qualifying text, such as bullet points, annotated bibliographies, etc., will not be processed and can create disparity between the submission
highlights and the percentage shown.

Submission ID
Page 2 of 7 - AI Writing trn:oid:::3012:558570917
Overview
 Submission ID
Page 3 of 7 - AI Writing trn:oid:::3012:558570917
Submission

Contemporary Issues in Project Management

 Title page
 Executive summary
Through their partnership within Operation Warp Speed both Moderna and Pfizer/BioNTech developed and
manufactured an mRNA COVID-19 vaccine that shortened delivery to fewer than twelve months thus
minimizing deaths and advancing economic growth. Project management evaluation studied both business
advantages along with outcomes including the prevention of 6 million deaths and $1.5 trillion U.S. GDP losses
and vaccine effectiveness at 94-95% and global implementation of the vaccine. At least three primary problems
were confronted by the project because of its accelerated speed requirements and production volume
demands and worldwide ethical vaccine distribution needs. The project encountered difficulties when it scaled
up public and global participation since this approach led to 25% US citizens refusing vaccinations by 2023
because stakeholder groups were inadequately included. Risk management activities resulted in delays for the
COVAX shipment deliveries. The two theoretical gaps concern stakeholder theory as proposed by Freeman and
PMBOK's risk framework. Research analysts reward the technical execution of the project while pointing out
operational trust and equity deficiencies. The execution of upcoming projects should combine both community
education programs and equal resource distribution schemes and better risk data dissemination protocols to
enhance technical effectiveness and produce beneficial social outcomes. A universal preparedness strategy for
similar occurrences should serve as a supplementary measure.
Table of contents
Section 1: Detailed description of the project
The mRNA COVID-19 Vaccine Project
Introduction
Through Operation Warp Speed (OWS) effective support was given to Moderna and Pfizer/BioNTech for
creating the mRNA COVID-19 vaccines that represented an unprecedented achievement within medical
science and project administration. The vaccine development process began in January 2020 after scientists
released the genetic sequence of SARS-CoV-2 in order to create a rapid vaccine program to fight the new
coronavirus from initial development to complete distribution. Worldwide COVID-19 tools became possible
after both Moderna's mRNA-1273 vaccine and Pfizer/BioNTechs BNT162b2 vaccine received emergency use
authorizations from the United States and the United Kingdom during December 2020 (HHS, 2020). The
creation of mRNA vaccine spikes follows an opposite approach to traditional vaccine making methods which
depend on inactive viruses. Scientists used new research approaches that allowed vaccine developers to
reduce their production time from the typical ten years down to less than a year according to Pardi et al.
(2018). The successful execution of this project needed a partnership between public and private organizations
as well as adaptive regulation frameworks to support $18 billion in government funding. The project needed to
address multiple hurdles to advance and its success depended on how different stakeholder interactions
functioned with risk management procedures. Extensive research becomes possible through the certain
comprehension of project advantages coupled with performance forecasting and precise project limits
definition.
Suggested Business Benefits
Multiple beneficial effects resulted from mRNA vaccine development that touched both healthcare structures
and manufacturing capabilities and supply safety mechanisms. Community recovery represented the
fundamental target of this COVID-19 project but its essential mission required lethal virus consequences
control. The COVID-19 pandemic became responsible for six million deaths throughout the middle of 2022

Submission ID
Page 3 of 7 - AI Writing trn:oid:::3012:558570917
Submission
 Submission ID
Page 4 of 7 - AI Writing trn:oid:::3012:558570917
Submission

thereby confirming the value of vaccinations per Watson et al. (2022). The economic recovery was possible
through vaccination programs which restored commercial operations together with more workers on the job
thus preventing an anticipated $1.5 trillion GDP gap in 2022 United States (CDC, 2021). Between 2021 and 2023
the manufacturing and development of Comirnaty and mRNA-1273 generated $36 billion for Moderna and
$11.22 billion for Pfizer/BioNTech. Current earnings demonstrate both companies' rising market position and
show mRNA's flexibility in making future medical treatments such as cancer vaccines and malaria prevention
vaccines (Pardi et al., 2018). Operation Warp Speed enabled the United States to increase its position as a
global health leader through successful cooperative relationships between government institutions and private
industries (HHS, 2020). Modern biotechnological research presents mRNA as its primary method thanks to the
systematically developed vaccine protocols found through the initiative which improved outbreak readiness
capabilities.
Expected Outcomes
The initiative operated with quantitative goals which serve as fundamental components to meet pandemic
requirements in a timely manner. The initiative developed vaccinations that reached 90% or superior efficiency
rates while meeting safety standards necessary for public mass vaccination programs. Both vaccines
maintained 94-95% effectiveness and showed uncommon side effects that triggered myocarditis symptoms in
less than 2-5 patients for every 100,000 trial participants (Watson et al., 2022). The project transitioned to fast
deployment as its essential goal after setting distribution authority objectives that required distributing 10-year
amounts within the following 12 months. The EUA approvals from December 2020 allowed Pfizer/BioNTech to
set their annual production goal at four billion doses for 2022 as they shipped numerous doses across the
world (CDC, 2021). The vaccine development project first focused on distributing to wealthy nations before
COVAX began serving as an additional distribution option. Millions of doses from this research provided
Modern science with evidence that mRNA technology is suitable for developing HIV vaccines and cancer
prevention medicine (Pardi et al., 2018). Manufacturers aimed to present the product as a protective measure
that reduced concerning manifestations to make business operations and schools function more safely.
Main Constraints
Project execution ran into substantial obstacles which generated execution obstacles during the
implementation phase. Development of the vaccine faced minimal difficulties since the typically ten-year
production schedule clashed with the urgent need for completion within one year (HHS, 2020). The FDA fixed
the situation and public reactions to their protocol method underwent significant changes. The rapid expansion
of vaccine manufacturing facilities and intricate logistics support and material supply became essential to
produce thousands of vaccine doses because Pfizer/BioNTech products needed -70°C temperature storage
conditions (CDC, 2021). The clinical trials needed between 30,000 and 46,000 participants to achieve quick
production while maintaining strict evaluation procedures. During its operation OWS donated $18 billion to
lower investment risks for private businesses through its initial funding process (HHS, 2020). The problem of
distributing vaccines justly could not resolve itself because wealthy nations obtained their first vaccine
allocation before developing states which impeded less fortunate nations from acquiring vaccines despite
stressing COVAX programs (Watson et al., 2022).
Impact of Contemporary Issues
Important changes in project direction emerged from essential project management elements which included
stakeholder participation with risk management. The successful project development occurred because every
stakeholder actively participated throughout its development process. Governments obtained funding as they
developed new policies which allowed regulatory bodies to authorize business entities to deliver services to
healthcare organizations serving the public for project success. The organizations successfully accessed grants
of $10.8 billion and $20.4 billion from HHS and FDA through their strategic high agency interactions (HHS,
2020). A vaccine skepticism emerged across 50% of American citizens who questioned vaccine security levels
Submission ID
Page 4 of 7 - AI Writing trn:oid:::3012:558570917
Submission
 Submission ID
Page 5 of 7 - AI Writing trn:oid:::3012:558570917
Submission

because of political applications of the “Warp Speed” label (CDC, 2021). Developing nations acquired
minimally distributed vaccine doses until 2022 according to Watson et al. (2022). Risk management systems
were implemented to tackle experimental failures within technical risks along with supply chain problems
which brought reputational damage from distrust. The OWS organization minimized supply chain
vulnerabilities through its early procurement of products along with its establishment of critical manufacturing
partnerships with Lonza and BioNTech at their Belgium plant site (HHS, 2020). According to HHS (2020) the
FDA showed flexibility in its trial assessment process to reduce time requirements. The release of a
whistleblower report by Ventavia along with opposing risk communication efforts led Watson et al. (2022) to
conclude Americans would keep rejecting vaccines until at least 2023 (25% population). Project growth
addressed dual challenges that occurred when they had to deploy swiftly yet maintain both trust and fairness
throughout vaccine development due to global pandemic monitoring.

Section 2: Systematic evaluation of the two main contemporary issues

Evaluation of Two Contemporary Issues

As part of the COVID-19 vaccination development Project Warp Speed delivered operational support to
Pfizer/BioNTech and Moderna providing mRNA vaccines to the market within a year which produced
extraordinary life-saving benefits and restructured global health crisis management. The development of this
project together with its end results received important input from basic contemporary stakeholder
involvement and risk management approaches. Academic research models enable the evaluation of project
development procedures by both measuring effective approaches and problems to apply in future projects.
The stakeholder engagement analysis uses Freeman's Stakeholder Theory with its Salience Model to integrate
them with PMBOK Guide Risk Management Framework and Chapman and Ward’s Uncertainty Management
Model in order to show how the project evolved into an elaborate system and provided structured approaches
for evaluating managerial approaches.

Exposition of Key Theories and Models

Stakeholder Engagement

Freeman’s Stakeholder Theory (1984)

The theory demands the development of solid connections to project stakeholders who participate or
influence projects no matter their shareholder status. Economic social and ethical stakeholders receive
attention from their stakeholders for need resolution which results in project goal achievement (Freeman
1984). The theory mandates organizations to acknowledge all entities affecting the project then establish
performance goals for them before working on team cooperation to merge their objectives.

Stakeholder Salience Model (Mitchell et al., 1997)

The model provides stakeholder management with greater effectiveness since it classifies stakeholders based
on their power status and legitimacy levels together with their requirement prioritization. Managers should
prioritize stakeholders with comprehensive characteristics in their stakeholder management program even
though organizations must develop singular support strategies for stakeholders with less comprehensive
characteristics (Mitchell et al., 1997). The organizational resource allocation through this method enables
proper control of advanced projects with multiple stakeholder group involvement.

Submission ID
Page 5 of 7 - AI Writing trn:oid:::3012:558570917
Submission
 Submission ID
Page 3 of 10 - AI Writing trn:oid:::3719:034759218
Submission

Risk Management

PMBOK Guide’s Risk Management Framework (PMI, 2017)

Risk management operations within the Project Management Body of Knowledge (PMBOK) unfold through
three specific processes starting from threat detection and evaluation and continuing to response planning
followed by active risk monitoring. Risk classification starts with analysis of probable events to evaluate their
impact and establishes between four risk management plans that begin with avoidance followed by mitigation
and transfer functions before moving toward accepting the remaining risks. Strategic project planning needs to
begin in advance and monitoring activities continue throughout for addressing unpredictable elements that
arise from dynamic project work (PMI, 2017).

Chapman and Ward’s Uncertainty Management Model (2003)

The model can advance risk management strategy effectiveness through expanded understanding of risk
uncertainty which adds potential issues and opportunities to conventional methods. The system applies risk
evaluation loops repeatedly and depends on group participation in understanding risks while adapting
response techniques to handle volatile project conditions. The model generates useful benefits for time-
sensitive projects when deficiencies in data create higher uncertainty (Chapman & Ward, 2003).

Application of Theories and Models to the Project

Stakeholder Engagement

The mRNA vaccine project united U.S. HHS and EU officials with British government members and FDA and
MHRA health authorities and pharmaceutical firms Moderna and Pfizer/BioNTech as well as healthcare
providers with public participants and COVAX and WHO entities. According to Freeman's Stakeholder Theory
the mRNA vaccine project required complete stakeholder engagement because different groups needed
connectivity through methods which allowed funding providers to unite with approval officials and vaccine
recipients to unite with equal distribution representatives. Through the Stakeholder Salience Model
stakeholders were able to locate the right place according to their unique characteristics.

Government and Regulators

Under both ethical and legal requirements the stakeholders exercised overwhelming influence to expedite
project responses because of the severe pandemic conditions. During standard HHS-FDA meetings the Open
Market Access and Payment Project of OWS distributed $18 billion dollars equally into two payments of $10.8
billion for Moderna and $20.4 billion for Pfizer/BioNTech (HHS, 2020). CDC indicated that healthcare system
organizations acquired market control by creating contracts which resulted in the purchase of 100 million Pfizer
doses for $1.95 billion (CDC, 2021).

Pharmaceutical Companies

Investment of $18 billion from Mohammad Aziz-Ulgait in behalf of OWS went to Moderna and Pfizer/BioNTech
because the companies met both legitimacy and urgency requirements for execution purposes. OWS
successfully handled their internal stakeholders by developing strategic partnerships with Lonza and the
BioNTech Belgium plant as well as Pfizer/BioNTech (Watson et al., 2022).

Public

People who came from the beneficiary population strongly supported the initiative even though they faced
pandemic risks at the same time they lacked official authority over decisions. Participants obtained weak trial
results because the engagement failed to provide adequate information about research safety protocols and
testing methodologies. The 2020 Gallup poll found Americans at 50% opted against vaccination since they
found Warp Speed's hasty speed of development untrustworthy (CDC, 2021). The Federal Retail Pharmacy

Submission ID
Page 3 of 10 - AI Writing trn:oid:::3719:034759218
Submission
 Submission ID
Page 4 of 10 - AI Writing trn:oid:::3719:034759218
Submission

Program issued their EUA approvals after misinformation about vaccines entered public consciousness so they
were unable to counter this already diffused information.

Global Stakeholders

COVAX together with poor nations having pressing demands had little influence over negotiations which
caused their help to arrive late because they held no power. During the initial vaccine supply distribution high-
income nations received 80% of the shares while COVAX projected it would deliver 1 billion doses during 2022
(Watson et al., 2022).
Project teams that disregard weak stakeholders according to Freeman's theory will create adverse effects that
obstruct project goal accomplishments. The speedy development came at the expense of vital stakeholders
although this decision negatively affected public trust and global fairness thus compromising enduring project
success.
Risk Management
Strategies for managing risks needed improvement due to possible technological issues during trials alongside
delays in both operational supply chain activities and public doubts about vaccine programs. Organizational risk
management followed PMBOK Framework standards to address unpredictable scenarios by implementing
solutions based on Chapman and Ward’s model.
Investigative tests revealed that trial-related safety failures combined with supply chain problems generated
substantial risks which were matched with moderately affecting public doubt about the project objectives.
Impacts from vaccine analysis at OWS served as the foundation through which they developed their risk
mapping approach using impact-risk evaluation strategies (HHS, 2020).
Risk Responses
The mRNA COVID-19 vaccine project utilized risk management approaches consisting of methods that satisfied
requirements from both PMBOK Framework as well as Chapman and Ward’s Uncertainty Management Model.
The vaccine received accelerated FDA approval across multiple testing stages thus shortening its overall
development period according to CDC (2021). The pharmaceutical industry invested $204 million into OWS
Corning vial manufacturing alongside Pfizer's Belgian plant expanded facilities until their initial delivery was
reduced to 50 million doses before their operations were finished (Watson et al., 2022). The project involved
detailed procedures to detect the uncommon adverse effect myocarditis following EUA approval (Dagan et al.,
2021). According to the Chapman and Ward model workers should maintain active involvement in risk
assessment processes regardless of whether their particular approach was used in specific projects. Despite
technical risk management success the disclosure of trial irregularities at Ventavia caused public doubt no
matter what the FDA approved (Lenzer, 2021). During 2023 the public refused vaccines because the project
administration did not explain vaccine safety risks properly leading to 25% of Americans keeping themselves
unvaccinated (CDC, 2021).
Issues Highlighted by the Application
Stakeholder Engagement Issues
Multiple unbalanced critical stakeholders involved in the mRNA COVID-19 vaccine project substantially affected
its resulting outcomes. OTS's $18 billion funding collaboration with stakeholders including regulatory bodies
provided the organization exceptional power in the project operation while neglecting public and developing
nations (HHS, 2020). Research findings indicate that COVID vaccine hesitancy reached 50% in 2020 yet experts
expect the rate to decrease to 25% by 2023 (Watson et al. 2022; GAVI 2023) despite COVAX experiencing
delivery delays due to countries with high incomes taking 80% of the 2021 vaccine allocation. The
dissemination of accurate information through X and neighborhood leadership activities could have improved
the correspondence between public expectation and correct information distribution. The equity issues
Submission ID
Page 4 of 10 - AI Writing trn:oid:::3719:034759218
Submission
 Submission ID
Page 5 of 10 - AI Writing trn:oid:::3719:034759218
Submission

present in this venture enable rich countries to select against Freeman's inclusive model of engagement
resulting in global health aims and viral strain distribution deficits (GAVI, 2023). Stakeholder distrust developed
from the "Warp Speed" slogan together with media-based rhetorical messages as described by Lenzer (2021)
which misled people about major project objectives.
Risk Management Issues
The mRNA COVID-19 vaccine project encountered multiple risks which produced different results in its final
output. Project management strategies within the PMBOK Framework successfully managed supply chain risks
yet Americans rejected vaccines at a rate of 25 percent by 2023 according to CDC (2021). Stakeholder
involvement in risk perception assessments failed during project communication per Chapman and Ward’s
Uncertainty Management Model which left the project without essential opportunities for building trust (GAVI,
2023). The Ventavia whistleblower controversy produced serious reputation issues when it revealed trial
problems revealing subcontractor mistakes in project oversight responsibilities (Lenzer 2021). The project
made an error in iterative risk monitoring according to Chapman and Ward while focusing on expedition for
public consent this led to late information challenges resulting in prolonged vaccine safety and performance
questions.
Although the mRNA vaccine program incorporated stakeholder communication along with risk precaution
systems it faced important limitations in these measures. The combination of Salience Model with Freeman’s
Stakeholder Theory shows how the project successfully engaged high-power stakeholders while neglecting
public relations with both average citizens and developing nations which caused public rejection extending into
economic imbalances. Technical risk management in the project gained positive assessment under PMBOK
Framework and Chapman and Ward’s model yet these evaluation methods detected flawed social and
reputational risk management that escalated distrust levels. Upcoming global health initiatives have to
combine their technical skills with broad-based risk management approaches to create public acceptance
while preserving procedural fairness in their operations.
Section 3: Reflections and recommendation
Reflections and Recommendations
Operation Warp Speed (OWS) speeded up Pfizer/BioNTech as well as Moderna's development of their mRNA
COVID-19 vaccine project while showcasing that human beings can both innovate powerfully and deliver
outstanding project management abilities. The vaccine development timeline of under one year marked an all-
time historical progress that granted permanent life-saving benefits together with game-changing global
healthcare systems. Congress created Operation Warp Speed for vaccine development but the actual vaccine
process revealed excellent operational outcomes while identifying weak points that required better safety
procedures and stakeholder communications. This analysis reviews historic project performance to derive
beneficial insights for future development projects using gained strategies from this major achievement.
View on Project Management
The mRNA vaccine project achieved operational excellence through its exceptional achievement of integrating
competent teamwork with innovative approaches and allocation capabilities in its operational and technical
management. OWS established an essential cooperative structure linking public health entities with private
companies to defend financial investments and maintain effective contact between HHS, FDA and Moderna
and Pfizer/BioNTech through their $18 billion funding plan (Gottlieb, 2021). The vaccine development
accelerated through parallel operational phases that reduced timelines and BioNTech united with Lonza to
construct their Belgium manufacturing facility which produced numerous billion vaccine doses (Bloomberg,
2022). High-power stakeholders granted EUAs to the project prior to December 2020 to show their successful
partnership in regulatory procedures (HHS, 2020). The extensive history of mRNA science research allowed
experts to precisely handle the platform so they could deliver 94-95% effectiveness rates (Polack et al., 2020).
Submission ID
Page 5 of 10 - AI Writing trn:oid:::3719:034759218
Submission
 Submission ID
Page 6 of 10 - AI Writing trn:oid:::3719:034759218
Submission

Social equity along with fairness in project administration received no recognition during the project
management phase. The inclusive process failed to achieve fairness in its governance by focusing almost
exclusively on authorities over the public or resource-poor nations. The initial level of American public vaccine
hesitation reached 50% in 2020 but it decreased to 25% by 2023 due to insufficient communication strategies
and the claim that Warp Speed accelerated vaccine development (CDC, 2021). COVAX needed to postpone its
vaccine delivery initiative because wealthy nations acquired virtually all vaccine doses in 2021 (Torjesen, 2021).
While the system demonstrated effective handling of technical supply chain threats the inadequate capabilities
to handle organizational reputation risks proved to be a drawback. Public opinion turned against the FDA
because they authorized product approval after their contractors were found to lack proper oversight and
respond inadequately to the trial misconduct (Lenzer, 2021). The emphasis on operational success within the
project management system results in minimal positive social effects due to its higher priority on organizational
benefits.
The project managers effectively handled crises however they did not build trust networks and failed to
provide resource access to everyone. Stakeholder power positions establish their capability to trigger issues
within management systems based on Freeman’s Stakeholder Theory (1984). The Uncertainty Management
Model applies public perception as an important risk element due to the emphasis it puts on dedicated
attention according to Chapman and Ward (2003). Worldwide inequalities require complete resolutions of
ethical and economic gaps which surfaced from the vaccine project's quick distribution success.
Discussion of Alternatives
Project success would improve by implementing alternative methods of stakeholder engagement and risk
management systems over the entire development period.
Proactive Public Engagement
Alternative
Before the EUA implementation the project needed to setup future-oriented communication systems by
creating partnerships between X and local health officials alongside reliable community members according to
Ricciardi (2017). Frequent reports about vaccine testing methods and protective measures and their potential
advantages over risks would have helped eliminate misleading information resulting in a decrease of vaccine
resistance to 50% in 2020 (CDC, 2021).
View
Under Freeman's Stakeholder Theory people would represent genuine stakeholders when matters directly
involved them. Better relationship building between public authorities would decrease projected unvaccinated
people to 19% in 2023 while improving vaccination numbers and health outcomes. Time constraints limited
our ability to develop proper resource organization yet the partnership between CDC networks and social
media platforms turned out to be cost-effective.
Prioritized Global Equity
The project would benefit from prompt execution of compulsory COVAX commitments for fulfilling worldwide
dose distribution needs. High-income states acquired 80% of vaccine availability in 2021 thus delaying
vaccination initiatives for lower-income nations according to Torjesen (2021). The combination of speed and
global equity demands would be possible through an agreement which forces COVAX to acquire 50 percent of
the vaccine supply.
The method Freeman applies matches the full participant involvement model with reduced global health risks
from variant transmission. The adequate use of $18 billion from the Overseas Development Initiative would
eliminate delivery delays for high-income nations and enable COVAX to optimize its distribution system. Such

Submission ID
Page 6 of 10 - AI Writing trn:oid:::3719:034759218
Submission
 Submission ID
Page 7 of 10 - AI Writing trn:oid:::3719:034759218
Submission

operational structure would produce positive ethical effects for the initiative while delivering worldwide health
gains but probably encounter pushback from donor nations.
Enhanced Contractor Oversight and Risk Communication:
The PMI (2017) suggested guidance for monitoring third parties would have prevented Ventavia from
conducting unregulated testing procedures causing public disbelief (Lenzer, 2021). The study would have
achieved better credibility as per Polack et al. (2020) by actively disclosing rare myocarditis reports found in 2-5
per 100,000 recipients.
Using Chapman and Ward’s model in this manner would lower extreme reputational risks which eventually led
to lower public skepticism toward the project. Better management of the implementation challenge would
have occurred through uniting FDA monitoring systems with public health network capabilities. The public
would have given stronger approval to this project at every stage of its lifecycle if operation measures were
made fully clear.
Institutionalized Preparedness Framework
The project needed to establish a permanent pandemic operation system which followed the framework
described by Gottlieb (2021). The sustained operation of an OWS-like framework produces immediate financial
backing together with flexible guidelines to promptly handle operational issues.
A preparedness framework developed through this project would achieve its established goals to sustain
preparedness operations. Initial project costs will generate returns because they prevent estimated GDP losses
amounting to $1.5 trillion according to CDC (2021). The upcoming WHO pandemic treaty negotiations during
2024 can provide a strong foundation despite expected difficulties to gain international political backing.
Recommendations
Multiple strategic recommendations for better future global health project management stem from both the
strengths and weaknesses of the mRNA COVID-19 vaccine initiative. Trust-building proves essential for creating
every operational framework because it functions as the base foundation. Changing global health initiatives
requires that teams first share crucial X information before selecting trusted members to implement trust-
building strategies developed by Ricciardi (2017). Public reception toward receiving the vaccine improved by
50% after authorities explained trial safety protocols to the public (CDC, 2021). Equity strategies must be
incorporated at the beginning of project development stages. Due to the binding COVAX commitment for
equal vaccine distribution high-income nations seized 80% of all doses throughout 2021 (Torjesen, 2021).
Through this approach developing countries would obtain vaccines without delays thus decreasing the
possibility of new variant emergence. A total enhancement of risk management procedures ensures the
achievement of superior outcomes. Folicula Medical would defend its reputation against this kind of damage
through the usage of PMI's contractor oversight protocol and Chapman and Ward's Uncertainty Management
Model proactive risk communication framework (PMI, 2017; Chapman & Ward, 2003; Lenzer, 2021). When
risks are fully disclosed with benefits during the communication process it helps develop new trust from the
public. The world needs an improved OWS-like system to enable quick financial distribution through flexible
regulations for achieving readiness as described by Gottlieb (2021). Through purposeful deployment of its
logistical achievements the project will establish future readiness. The conclusion of any project demands full
reviews which must be established as essential requirements. WHO plans to create its 2024 pandemic treaty
and future crisis initiatives through documenting its stakeholder involvement and risk management
frameworks which enable knowledge-based foundation development. These recommendations have dual
purposes because they fulfill international obligations both through technical requirements and public trust to
generate enhanced pandemic responses for upcoming health disasters.

Submission ID
Page 7 of 10 - AI Writing trn:oid:::3719:034759218
Submission
 Submission ID
Page 8 of 10 - AI Writing trn:oid:::3719:034759218
Submission

Conclusion
The development of lifesaving mRNA vaccines occurred because powerful partnerships and innovation
achievements together with record-breaking delivery speed enabled operational and technical management
success. The vaccine project demonstrated exceptional scientific advancement despite insufficient stakeholder
partnerships leading people to doubt and misuse the vaccine because of this lack of involvement. The solution
would be more powerful if society received advance educational campaigns and if distribution systems
operated neutrally and if preparedness protocols were strengthened. A comprehensive approach to project
management requires technological abilities to work effectively with public trust and global social
accountability during crisis management for achieving equivalent meaningful results.

Submission ID
Page 8 of 10 - AI Writing trn:oid:::3719:034759218
Submission
 Submission ID
Page 9 of 10 - AI Writing trn:oid:::3719:034759218
Submission

Bibliography
Centers for Disease Control and Prevention (CDC). (2021). COVID-19 vaccine distribution and administration
data. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/distribution.html
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018). mRNA vaccines—a new era in vaccinology. Nature
Reviews Drug Discovery, 17(4), 261–279. https://doi.org/10.1038/nrd.2017.243
U.S. Department of Health and Human Services (HHS). (2020). Operation Warp Speed: Accelerating the
development of COVID-19 vaccines. Retrieved from https://www.hhs.gov/coronavirus/operation-warp-
speed/index.html
Watson, O. J., Barnsley, G., Toor, J., Hogan, A. B., Winskill, P., & Ghani, A. C. (2022). Global impact of the first
year of COVID-19 vaccination: A mathematical modelling study. The Lancet Infectious Diseases, 22(9), 1293–
1302. https://doi.org/10.1016/S1473-3099(22)00320-6

Centers for Disease Control and Prevention (CDC). (2021). COVID-19 vaccine distribution and administration
data. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/distribution.html

Chapman, C., & Ward, S. (2003). Project risk management: Processes, techniques and insights. John Wiley & Sons.

Dagan, N., Barda, N., Kepten, E., Miron, O., Perchik, S., Katz, M. A., ... & Balicer, R. D. (2021). BNT162b2 mRNA
Covid-19 vaccine in a nationwide mass vaccination setting. New England Journal of Medicine, 384(15), 1412–
1423. https://doi.org/10.1056/NEJMoa2101765

Freeman, R. E. (1984). Strategic management: A stakeholder approach. Pitman Publishing.

GAVI, The Vaccine Alliance. (2023). COVAX: Ensuring global equitable access to COVID-19 vaccines. Retrieved
from https://www.gavi.org/covax

Lenzer, J. (2021). Covid-19: Whistleblower raises concerns about data integrity in Pfizer’s vaccine trial. BMJ,
375, n2635. https://doi.org/10.1136/bmj.n2635

Mitchell, R. K., Agle, B. R., & Wood, D. J. (1997). Toward a theory of stakeholder identification and salience:
Defining the principle of who and what really counts. Academy of Management Review, 22(4), 853–886.
https://doi.org/10.5465/amr.1997.9711022105

Project Management Institute (PMI). (2017). A guide to the project management body of knowledge (PMBOK
Guide) (6th ed.). PMI.

Submission ID
Page 9 of 10 - AI Writing trn:oid:::3719:034759218
Submission
 Submission ID
Page 10 of 10 - AI Writing trn:oid:::3719:034759218
Submission

U.S. Department of Health and Human Services (HHS). (2020). Operation Warp Speed: Accelerating the
development of COVID-19 vaccines. Retrieved from https://www.hhs.gov/coronavirus/operation-warp-
speed/index.html

Watson, O. J., Barnsley, G., Toor, J., Hogan, A. B., Winskill, P., & Ghani, A. C. (2022). Global impact of the first
year of COVID-19 vaccination: A mathematical modelling study. The Lancet Infectious Diseases, 22(9), 1293–
1302. https://doi.org/10.1016/S1473-3099(22)00320-6

Bloomberg. (2022). How Pfizer and BioNTech scaled up vaccine production. Retrieved from
https://www.bloomberg.com/news/articles/2022-01-17/how-pfizer-and-biontech-scaled-up-vaccine-
production
Gottlieb, S. (2021). Operation Warp Speed: A case study in public-private partnerships. Health Affairs Blog.
https://doi.org/10.1377/hblog20210225.344268
Ricciardi, W. (2017). Building trust in vaccination: Challenges and opportunities. Vaccine, 35(Supplement 1), A63–
A65. https://doi.org/10.1016/j.vaccine.2017.06.064
Torjesen, I. (2021). Covid-19: Vaccine inequity risks prolonging the pandemic, warn global health leaders. BMJ,
374, n2193. https://doi.org/10.1136/bmj.n2193

Submission ID
Page 10 of 10 - AI Writing trn:oid:::3719:034759218
Submission